Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shinotoh

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Neuropharmacology|March 1, 1991
Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomographyM Iyo, T Itoh, T Yamasaki, et al.
Annals of Neurology|August 12, 2000
Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography studyH Shinotoh, H Namba, K Fukushi, et al.
Lancet (London, England)|June 21, 1997
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's diseaseM Iyo, H Namba, K Fukushi, et al.
Annals of the New York Academy of Sciences|May 2, 2003
The amygdala and Alzheimer's disease: positron emission tomographic study of the cholinergic systemH Shinotoh, K Fukushi, S Nagatsuka, et al.
European Journal of Nuclear Medicine|February 5, 1999
Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of ageH Namba, M Iyo, K Fukushi, et al.
Neurology|May 1, 1997
Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover studyH Shinotoh, F J Vingerhoets, C S Lee, et al.
Annals of Neurology|July 13, 1999
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsyH Shinotoh, H Namba, M Yamaguchi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2001
Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's diseaseN Tanaka, K Fukushi, H Shinotoh, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 1, 1989
[Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET]M Iyo, T Yamasaki, H Fukuda, et al.
Psychopharmacology|January 1, 1989
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomographyH Shinotoh, M Iyo, T Yamada, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Neuropharmacology|March 1, 1991
Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomographyM Iyo, T Itoh, T Yamasaki, et al.
Annals of Neurology|August 12, 2000
Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography studyH Shinotoh, H Namba, K Fukushi, et al.
Lancet (London, England)|June 21, 1997
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's diseaseM Iyo, H Namba, K Fukushi, et al.
Annals of the New York Academy of Sciences|May 2, 2003
The amygdala and Alzheimer's disease: positron emission tomographic study of the cholinergic systemH Shinotoh, K Fukushi, S Nagatsuka, et al.
European Journal of Nuclear Medicine|February 5, 1999
Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of ageH Namba, M Iyo, K Fukushi, et al.
Neurology|May 1, 1997
Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover studyH Shinotoh, F J Vingerhoets, C S Lee, et al.
Annals of Neurology|July 13, 1999
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsyH Shinotoh, H Namba, M Yamaguchi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2001
Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's diseaseN Tanaka, K Fukushi, H Shinotoh, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 1, 1989
[Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET]M Iyo, T Yamasaki, H Fukuda, et al.
Psychopharmacology|January 1, 1989
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomographyH Shinotoh, M Iyo, T Yamada, et al.
Pageof 5